Environmental risks for nontuberculous mycobacteria: Individual exposures and climatic factors in the cystic fibrosis population

Annals of the American Thoracic Society

Volumn 11, Issue 7, 2014, Pages 1032-1038

  Prevots, D Rebecca ^a   Adjemian, Jennifer ^a,b   Fernandez, Aisling G ^a   Knowles, Michael R ^c   Olivier, Kenneth N ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b U S PUBLIC HEALTH SERVICE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cystic fibrosis; Environmental; Epidemiology; Nontuberculous mycobacteria

Indexed keywords

DRINKING WATER; TAP WATER; WATER; WELL WATER;

ADULT; AEROSOL; ARTICLE; ATMOSPHERIC MOISTURE; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BACTERIAL GROWTH; BACTERIAL SURVIVAL; CASE CONTROL STUDY; CLIMATE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYSTIC FIBROSIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FEMALE; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; INFECTION RISK; LAKE; LUNG DISEASE; MALE; PERSONAL HYGIENE; POND; PREVALENCE; QUESTIONNAIRE; RISK ASSESSMENT; SOIL; STREAM (RIVER); SWIMMING; TOOTH BRUSHING; WATER SUPPLY; ADVERSE EFFECTS; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; ENVIRONMENT; FOLLOW UP; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; ODDS RATIO; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; UNITED STATES;

ADULT; CASE-CONTROL STUDIES; CLIMATE; COHORT STUDIES; CONFIDENCE INTERVALS; CYSTIC FIBROSIS; ENVIRONMENT; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; ODDS RATIO; PREVALENCE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84911897085     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201404-184OC     Document Type: Article

References (22)

1. Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med 2012;185:881-886.
2. Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 2010;182:970-976.
3. Dirac MA, Horan KL, Doody DR, Meschke JS, Park DR, Jackson LA, Weiss NS, Winthrop KL, Cangelosi GA. Environment or host? A case-control study of risk factors for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2012;186:684-691.
4. Kim RD, Greenberg DE, Ehrmantraut ME, Guide SV, Ding L, Shea Y, Brown MR, Chernick M, Steagall WK, Glasgow CG, et al. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med 2008;178:1066-1074.
5. Olivier KN, Weber DJ, Wallace RJ Jr, Faiz AR, Lee JH, Zhang Y, Brown-Elliot BA, Handler A, Wilson RW, Schechter MS, et al.; Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003;167:828-834.
6. Feazel LM, Baumgartner LK, Peterson KL, Frank DN, Harris JK, Pace NR. Opportunistic pathogens enriched in showerhead biofilms. Proc Natl Acad Sci USA 2009;106:16393-16399.
7. Falkinham JO III. Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease. Emerg Infect Dis 2011;17:419-424.
8. Prevots DR, Adjemian J, Fernandez AG, Knowles M, Olivier KN. Environmental exposures to nontuberculous mycobacteria among persons with cystic fibrosis: the risk of individual exposures and the association of climatic factors in disease prevalence [abstract]. Am J Respir Crit Care Med 2010;181.1:A2604.
9. Dailloux M, Hartemann P, Beurey J. Study on the relationship between isolation of mycobacteria and classical microbiological and chemical indicators of water quality in swimming pools. Zentralbl Bakteriol Mikrobiol Hyg [B] 1980;171:473-486.
10. Havelaar AH, Berwald LG, Groothuis DG, Baas JG. Mycobacteria in semi-public swimming-pools and whirlpools. Zentralbl Bakteriol Mikrobiol Hyg [B] 1985;180:505-514.
11. Taylor RH, Falkinham JO III, Norton CD, LeChevallier MW. Chlorine, chloramine, chlorine dioxide, and ozone susceptibility of Mycobacterium avium. Appl Environ Microbiol 2000;66:1702-1705.
12. Covert TC, Rodgers MR, Reyes AL, Stelma GN Jr. Occurrence of nontuberculous mycobacteria in environmental samples. Appl Environ Microbiol 1999;65:2492-2496.
13. Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, et al.; Gene Modifier Study Group. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 2005;353:1443-1453.
14. Cutting GR. Modifier genes in Mendelian disorders: the example of cystic fibrosis. Ann N Y Acad Sci 2010;1214:57-69.
15. Reed C, von Reyn CF, Chamblee S, Ellerbrock TV, Johnson JW, Marsh BJ, Johnson LS, Trenschel RJ, Horsburgh CR Jr. Environmental risk factors for infection with Mycobacterium avium complex. Am J Epidemiol 2006;164:32-40.
16. Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 1969;99(4 Suppl):12-14.
17. Adjemian J, Olivier KN, Seitz AE, Falkinham JO III, Holland SM, Prevots DR. Spatial clusters of nontuberculous mycobacterial lung disease in the United States. Am J Respir Crit Care Med 2012;186:553-558.
18. Kirschner RA Jr, Parker BC, Falkinham JO III. Epidemiology of infection by nontuberculous mycobacteria: Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum in acid, brown-water swamps of the southeastern United States and their association with environmental variables. Am Rev Respir Dis 1992;145:271-275.
19. Collaco JM, McGready J, Green DM, Naughton KM, Watson CP, Shields T, Bell SC, Wainwright CE, Cutting GR; ACFBAL Study Group. Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study. PLoS ONE 2011;6:e27784.
20. Cystic Fibrosis Trust. Antibiotic treatment for cystic fibrosis: report of the UK Cystic Fibrosis Trust Antibiotic Group, 3rd edition. Bromley, UK: UK Cystic Fibrosis Trust; May 2009. Available from: https://www.cysticfibrosis.org.uk/media/82010/CD-Antibiotic-treatment-for-CF-May-09.pdf
21. Saiman, L Siegel JD, LiPuma JJ, Brown RJ, Bryson EA, Chambers MJ, Downer VS, Fliege J, Hazle LA, et al. Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 update. Infect Control Hosp Epidemiol 2014;35 Suppl 1:S1-S67.
22. Glazer CS, Martyny JW, Lee B, Sanchez TL, Sells TM, Newman LS, Murphy J, Heifets L, Rose CS. Nontuberculous mycobacteria in aerosol droplets and bulk water samples from therapy pools and hot tubs. J Occup Environ Hyg 2007;4:831-840.